TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000441012 NR1H3 NA NA prostate cancer up-regulated predicted more...
ENST00000441012 NR1H3 NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000441012 NR1H3 NA NA renal cell cancer up-regulated predicted more...
ENST00000441012 NR1H3 NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000441012 NR1H3 NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000441012 NR1H3 NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000441012 NR1H3 DB07080 TO-901317 autoimmune uveitis up-regulated validated more...
ENST00000441012 NR1H3 NA Nectandrin B nonalcoholic fatty liver disease down-regulated validated more...
ENST00000441012 NR1H3 NA Oleanolic acid nonalcoholic fatty liver disease down-regulated validated more...
ENST00000441012 NR1H3 NA Liver X receptors parkinson disease up-regulated validated more...
ENST00000441012 NR1H3 DB01094 Hesperetin atherosis up-regulated validated more...
ENST00000441012 NR1H3 NA Polyunsaturated fatty acids cardiovascular disease up-regulated validated more...
ENST00000441012 NR1H3 (LXRα) DB07080 TO-901317 hepatocellular carcinoma up-regulated validated more...